X-linked Osteoporosis due to PLS3 Pathogenic Variant: Case Report on Zoledronic Acid Treatment in Siblings
PDF

Case Report

X-linked Osteoporosis due to PLS3 Pathogenic Variant: Case Report on Zoledronic Acid Treatment in Siblings

J Clin Res Pediatr Endocrinol 2026;18(3):543-548 DOI: 10.4274/jcrpe.galenos.2025.2025-4-2
,
PDF
Permissions

Abstract

Osteoporosis in children is a rare condition, often associated with genetic factors. Monogenic forms of osteoporosis linked to the X chromosome are often related to mutations in the gene encoding plastin 3 (PLS3). PLS3 is a protein involved in actin bundle formation in the cytoskeleton. We present two brothers with recurrent peripheral fractures and vertebral compression fractures, both associated with low bone mineral density (BMD). The patients shared the same deletion (c.589_590) in PLS3 on Xq23, which was confirmed by next-generation sequencing. They were treated with zoledronic acid, calcium, and vitamin D, showing optimal improvement in BMD, a reduction in bone fractures, and enhanced quality of life.

Keywords: Bone diseases, Juvenile osteoporosis, PLS3, Zoledronic acid

Read the full text

3 sections · 3 figures · 2 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Kämpe AJ, Costantini A, Mäkitie RE, Jäntti N, Valta H, Mäyränpää M, Kröger H, Pekkinen M, Taylan F, Jiao H, Mäkitie O. PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants. Osteoporos Int. 2017;28:3023-3032. Epub 2017 Jul 26

2

Mäkitie O, Zillikens MC. Early-onset osteoporosis. Calcif Tissue Int. 2021;110:546-561. Epub 2021 Jul 8

3

Costa A, Martins A, Machado C, Lundberg E, Nilsson O, Wang F, Costantini A, Tournis S, Höppner J, Grasemann C, Mäkitie O. PLS3 mutations in X-linked osteoporosis: clinical and genetic features in five new families. Calcif Tissue Int. 2024;114:157-170. Epub 2023 Dec 3

4

Fahiminiya S, Majewski J, Al-Jallad H, Moffatt P, Mort J, Glorieux FH, Roschger P, Klaushofer K, Rauch F. Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J Bone Miner Res. 2014;29:1805-1814.

5

Durán P, Merker A, Briceño G, Colón E, Line D, Abad V, Del Toro K, Chahín S, Matallana AM, Lema A, Llano M, Céspedes J, Hagenäs L. Colombian reference growth curves for height, weight, body mass index and head circumference. Acta Paediatr. 2016;105:116-125. Epub 2015 Dec 27

6

Farella I, Chiarito M, Vitale R, D’Amato G, Faienza MF. The “Burden” of childhood obesity on bone health: a look at prevention and treatment. Nutrients. 2025;17:491.

7

Emeriau F, Amsellem-Jager J, Bouhours-Nouet N, Donzeau A, Rouleau S, Rerat S, Labarre E, Levaillant L, Coutant R. Insufficient bone mineralization to sustain mechanical load of weight in obese boys: a cross-sectional study. J Clin Endocrinol Metab. 2024;109:1443-1453.

8

Robledillo Lopez J. Evaluación y tratamiento de la osteoporosis en niños. Pediatr Integral. 2017;21:160-169.

9

Lv F, Ma M, Liu W, Xu X, Song Y, Li L, Jiang Y, Wang O, Xia W, Xing X, Qiu Z, Li M. A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid. Osteoporos Int. 2017;28:2691-2700. Epub 2017 Jun 16